931
Views
3
CrossRef citations to date
0
Altmetric
Case Report

Severe pyoderma gangrenosum in association with a flame burn

, , , &
Pages 1-6 | Received 29 Oct 2015, Accepted 27 Jan 2016, Published online: 04 Mar 2016

References

  • Cox NH, Jorizzo JL, Bourke JF. Vasculitis and neutrophilic vascular reactions. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook’s textbook of dermatology. Vol. 3, 8th edn. Oxford: Blackwell Science; 2010. p. 64–73.
  • Prat L, Bouaziz JD, Wallach D, et al. Neutrophilic dermatoses as systemic diseases. Clin Dermatol. 2014;32:376–388.
  • Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. Brit Med J. 2006;333:181–184.
  • Patel F, Fitzmaurice S, Duong C, et al. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015;95:525–531.
  • Napoli B, D’Arpa N, Conte F. Pyoderma gangrenosum and full-thickness burns: is there a problem of differential diagnosis? Ann Burns Fire Disasters. 2006;19:71–73.
  • Brocq L. Nouvelle contribution a l'étude du phagédénisme géométrique. Ann Dermatol Syphiligr. 1916;6:1–39.
  • Brunsting LA, Goeckerman WH, O’Leary PA. Pyoderma gangrenosum: clinical and experimental observation in five cases occurring in adults. Arch Dermatol. 1930;22:655–680.
  • Ouazzani A, Berthe JV, de Fontaine S. Post-surgical pyoderma gangrenosum: a clinical entity. Acta Chir Belg. 2007;107:424–428.
  • Baldea A, Gamelli RL. Postoperative pyoderma gangrenosum after elective abdominoplasty: a case report and review of the literature. J Burn Care Res. 2010;31:959–963.
  • MacKenzie D, Moiemen N, Frame JD. Pyoderma gangrenosum following breast reconstruction. Br Plast Surg. 2000;53:441–443.
  • Poritz LS, Lebo MA, Bobb AD, et al. Management of peristomal pyoderma gangrenosum. J Am Coll Surg. 2008;206:311–315.
  • West CC, Morritt AN, Ralston DR. Pyoderma gangrenosum in burns: a report of 3 cases and review of the literature. Burns. 2010;36:56–59.
  • Kalu PU, Greg Williams. Scalding as an unusual cause of pyoderma gangrenosum. Burns. 2007;33:105–108.
  • Barańska-Rybak W, Kakol M, Naesstrom M, et al. A retrospective study of 12 cases of pyoderma gangrenosum: why we should avoid surgical intervention and what therapy to apply. Am Surg. 2011;77:1644–1649.
  • Alavi A, Sajic D, Cerci FB, et al. Neutrophilic dermatoses: an update. Am J Clin Dermatol. 2014;15:413–423.
  • Schinkel C, Zimmer S, Kremer JP, et al. Comparative analysis of transcription and protein release of the inflammatory cytokines interleukin-1 beta (IL-1 beta) and interleukin-8 (IL-8) following major burn and mechanical trauma. Shock. 1995;4:241–246.
  • Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011;41:1203–1217.
  • Schimmer BP, Funder JW. ACTH, adrenal steroids, and pharmacology of the adrenal cortex. In: Brunton LL, Chabner BA, Knollman BC, editors. Goodman and Gilman's The pharmacological basis of therapeutics. New York: McGraw Hill Medical; 2011. p. 1209–1236.
  • Liaqat M, Elsensohn AN, Hansen CD, et al. Acute postoperative pyoderma gangrenosum case and review of literature identifying chest wall predominance and no recurrence following skin grafts. J Am Acad Dermatol. 2014;71:e145–e146.
  • Kim HS, Kim JH, Yim H, Kim D. Changes in the levels of interleukins 6, 8, and 10, tumor necrosis factor alpha, and granulocyte-colony stimulating factor in Korean burn patients: relation to burn size and postburn time. Ann Lab Med. 2012; 32:339–344.
  • Schmidt A, Bengtsson A, Tylman M, Blomqvist L. Pro-inflammatory cytokines in elective flap surgery. J Surg Res. 2007;137:117–121.